137 related articles for article (PubMed ID: 14597758)
1. The TRAIL to arthritis.
Tsokos GC; Tsokos M
J Clin Invest; 2003 Nov; 112(9):1315-7. PubMed ID: 14597758
[TBL] [Abstract][Full Text] [Related]
2. Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium.
Yao Q; Wang S; Gambotto A; Glorioso JC; Evans CH; Robbins PD; Ghivizzani SC; Oligino TJ
Gene Ther; 2003 Jun; 10(12):1055-60. PubMed ID: 12776164
[TBL] [Abstract][Full Text] [Related]
3. On the TRAIL of an arthritis cure.
Evans CH
Gene Ther; 2004 May; 11(9):735-6. PubMed ID: 15014428
[No Abstract] [Full Text] [Related]
4. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice.
Lamhamedi-Cherradi SE; Zheng SJ; Maguschak KA; Peschon J; Chen YH
Nat Immunol; 2003 Mar; 4(3):255-60. PubMed ID: 12577054
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3.
Perlman H; Nguyen N; Liu H; Eslick J; Esser S; Walsh K; Moore TL; Pope RM
Arthritis Rheum; 2003 Nov; 48(11):3096-101. PubMed ID: 14613271
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.
Zhang H; Yang Y; Horton JL; Samoilova EB; Judge TA; Turka LA; Wilson JM; Chen Y
J Clin Invest; 1997 Oct; 100(8):1951-7. PubMed ID: 9329958
[TBL] [Abstract][Full Text] [Related]
7. The suicide in the thymus, a twisted trail.
Green DR
Nat Immunol; 2003 Mar; 4(3):207-8. PubMed ID: 12605225
[No Abstract] [Full Text] [Related]
8. CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis.
Liu Z; Xu X; Hsu HC; Tousson A; Yang PA; Wu Q; Liu C; Yu S; Zhang HG; Mountz JD
J Clin Invest; 2003 Nov; 112(9):1332-41. PubMed ID: 14597760
[TBL] [Abstract][Full Text] [Related]
9. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.
Ishikawa E; Nakazawa M; Yoshinari M; Minami M
J Virol; 2005 Jun; 79(12):7658-63. PubMed ID: 15919918
[TBL] [Abstract][Full Text] [Related]
10. Cancer gene therapy using a novel secretable trimeric TRAIL.
Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
[TBL] [Abstract][Full Text] [Related]
11. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY
Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667
[TBL] [Abstract][Full Text] [Related]
12. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY
Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754
[TBL] [Abstract][Full Text] [Related]
13. Enhanced TRAIL sensitivity by E1A expression in human cancer and normal cell lines: inhibition by adenovirus E1B19K and E3 proteins.
Hu B; Zhu H; Qiu S; Su Y; Ling W; Xiao W; Qi Y
Biochem Biophys Res Commun; 2004 Dec; 325(4):1153-62. PubMed ID: 15555548
[TBL] [Abstract][Full Text] [Related]
14. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
Saitou Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Hum Pathol; 2005 Oct; 36(10):1066-73. PubMed ID: 16226105
[TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
Yoo J; Choi S; Hwang KS; Cho WK; Jung CR; Kwon ST; Im DS
J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019
[TBL] [Abstract][Full Text] [Related]
16. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
[TBL] [Abstract][Full Text] [Related]
17. The secretable form of trimeric TRAIL, a potent inducer of apoptosis.
Kim MH; Billiar TR; Seol DW
Biochem Biophys Res Commun; 2004 Sep; 321(4):930-5. PubMed ID: 15358116
[TBL] [Abstract][Full Text] [Related]
18. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.
Michowitz Y; Goldstein E; Roth A; Afek A; Abashidze A; Ben Gal Y; Keren G; George J
J Am Coll Cardiol; 2005 Apr; 45(7):1018-24. PubMed ID: 15808757
[TBL] [Abstract][Full Text] [Related]
19. Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis.
Terzioglu E; Bisgin A; Sanlioglu AD; Ulker M; Yazisiz V; Tuzuner S; Sanlioglu S
Rheumatology (Oxford); 2007 May; 46(5):783-9. PubMed ID: 17309888
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a combined, adenovirus-mediated oncolytic and immunostimulatory tumor therapy.
Bernt KM; Ni S; Tieu AT; Lieber A
Cancer Res; 2005 May; 65(10):4343-52. PubMed ID: 15899826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
